|
|||||||||||||||||||||||||
Jun. 2006 | GR18.1 Dec. 2004 | GR17.2 Sep. 2004 | GR17.1 Nov. 2003 | GR16.2 Mar. 2003 | GR16.1 Feb. 2002 | GR15.1 Feb. 2001 | GR14.1 Aug. 2000 | GR13.1 Dec. 1999 | GR12.1 Dec. 1998 | GR11.2 Jul. 1998 | GR11.1 Dec. 1997 | GR10.1 Dec. 1996 | GR9.1 Dec. 1995 | GR8.2 Jun. 1995 | GR8.1 Sep. 1994 | GR7.1 Dec. 1993 | GR6.2 May. 1993 | GR6.1
|
|||||||||||||||||||||||||
*****Glen Research Glen Report***** ULTRAMILD DNA SYNTHESISIn recent years, the synthesis of labelled oligonucleotides has
become virtually a standard procedure in many labs. Many labelling
reagents, e.g., biotin, fluorescein are now available as
ß-cyanoethyl (CE) phosphoramidites and this provides a rapid
means of producing the appropriate oligonucleotides directly. Prior
to the availability of these labelling reagents as CE
phosphoramidites, conjugations were carried out using the solution
phase reaction of amino-or thiol- modified oligonucleotides with the
appropriately functionalized label. Labels which are currently
available as CE phosphoramidites have one property in common - they
must be stable to strongly alkaline conditions required for removal
of the base protecting groups. This property is lacking in several
interesting dyes and labels and so we have been seeking an
alternative protecting scheme for the normal CE phosphoramidites
which allows UltraMILD deprotection and should not react with a wider
variety of tags and labels. References: (1) L.J. Marnett, Vanderbilt University Medical Center, Personal
Communication. ORDERING INFORMATION FOR LATEST GROUP OF ULTRAMILD SYNTHESIS COMPOUNDS |
|||||||||||||||||||||||||
Please contact Glen Research if you have any questions or comments! | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||